DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look
VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making
HEALTH RESEARCH VIDEO + ARTICLE: Can a retinal-scan at an early age predict future development of Alzheimer’s? Can you use that prediction to lessen your
VIDEO + ARTICLE: Aducanumab for Alzheimer’s is showing encouraging results as Phase 3 trials roll out. See how this new immunotherapy is treating Alzheimer’s at
VIDEO + ARTICLE: In an effort to educate potential volunteers to try RVT-101 in a clinical trial, the MINDSET STUDY is trying something new. Doctors
Axovant launches nelotanserin and 3 new clinical programs to treat Lewy body dementia. Also, their drug RVT-101 for Dementia with Lewy Bodies and Alzheimer’s gets
CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy
CLINICAL TRIALS VIDEO: 2015 has seen a big jump in the number of people volunteering for dementia research. Find out more about this hopeful surge
CNN VIDEO + INFO: Amyloid plaque buildup on the brain can begin decades before it actually triggers Alzheimer’s. See how The A4 Trial hopes to
In Phase 2 trials, Anavex performed as much as 4 times better than Aricept®, today’s most popular Alzheimer’s medication. The pill achieved cognitive and functional
FREE DOWNLOAD: This booklet is rich with care practices based on research by highly-credentialed investigators.
MARIJUANA VIDEO – Dr. Gregger:
Vascular dementia often results from strokes. In a huge study of 2 million pot smokers, hospitalization from ischemic stroke increased 17%. See more about this vascular-dementia-marijuana connection.
MAUDE’S AWARDS RECOGNIZE AND REWARD INNOVATIVE CARE
FOR PERSONS LIVING WITH ALZHEIMER’S DISEASE. AWARD APPLICATIONS OPEN NOW!
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
